Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM

ClinicalTrials.gov ID: NCT00004146

Public ClinicalTrials.gov record NCT00004146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Clinical and Pharmacologic Study of Radiation Therapy and CAI (Carboxy-Amido Triazole) in Adults With Newly Diagnosed Glioblastoma Multiforme

Study identification

NCT ID
NCT00004146
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
55 participants

Conditions and interventions

Interventions

  • radiation therapy Radiation
  • carboxyamidotriazole Drug
  • pharmacological study Other

Radiation · Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2000
Primary completion
Dec 31, 2009
Completion
Dec 31, 2009
Last update posted
May 7, 2015

2000 – 2010

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
University of Alabama Birmingham Birmingham Alabama 35294
Moffitt Cancer Center Tampa Florida 33612
Emory University/Winship Cancer Institute Atlanta Georgia 30322
Johns Hopkins University Baltimore Maryland 21287
Henry Ford Hospital Detroit Michigan 48202
Wake Forest University Winston-Salem North Carolina 27157
University of Pennsylavania/Abramson Cancer Center Philadelphia Pennsylvania 19104
University of Texas Health Science Center at San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00004146 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →